Talking to mainstream media about diabetes seems to be one of the biggest mysteries of life, does it not? When a big news story hits, we’re often faced with one perpetuated myth after another. For example, recent headlines screamed that the CDC is now speculating that 1 in 3 people in the US will have diabetes by 2050, but most stories didn’t specify that they meant type 2 diabetes exclusively. Big difference, right? Everyone from…Read more »
Earlier this week, Novo Nordisk released results of a sweeping new survey about how patients — both type 1 and type 2 — struggle with insulin therapy, and what doctors accredit that to.
Entitled the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM), the survey was conducted among almost 3,000 physicians and patients in eight countries “with the objective to learn what they perceive to be the biggest functional and emotional unfulfilled needs…
Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…Read more »
There are so many great events around empowered patients and consumer-driven healthcare in the Fall. It also being soccer season, the kickoff of the school year, and time for nearly every existing Jewish holiday, I can’t possibly attend as many as I’d like to. This makes me especially thankful to have some good D-blogger friends, such as Allison Blass, who recently attended one of these key conferences, and reports back to DiabetesMine today:
A Guest…Read more »
Forget about risk factors: nothing gives people the “diabetes wake-up call” like getting diagnosed yourself — or living through it with a loved one. The latter is what happened recently to Academy-Award winner Olympia Dukakis, whose husband Louis Zorich was diagnosed with type 2 diabetes last winter.
Suddenly, diabetes awareness was a top-of-mind issue for the couple, as they realized that early screening may have saved Louis’ life and limb. Olympia has joined forces with…